Global Variations in Blood Collection: What Explains the Differences?
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, has shared a post on LinkedIn:
”Blood Donation: Why do collection volumes vary by country?
You might think that donating blood is the same experience everywhere.
However, the volume collected depends… on the country! And that’s no coincidence.
In France, the standard volume is 475mL per donation. This is very close to what’s practiced in Germany, Canada, or the United States, where 500mL is collected. Why? Because the average body size is larger, and recommendations are adapted to donors’ physiology.
It’s important to know that the volume collected never exceeds 13% of donor’s total blood volume. Additionally, standard volumes are always given with a margin of about ±10% to account for individual variations.
Conversely, in several Asian countries, the volume is reduced. In Vietnam, for example, a standard donation is 𝟯𝟱𝟬 𝗺𝗟. In China, donors can even choose: 200, 300, or 400 mL. These smaller volumes take into account average body weight, hemoglobin levels, and local medical standards.
These differences reflect not only morphological realities but also cultural and regulatory approaches to public health. Some countries favor more frequent donations but in smaller amounts, while others focus on larger volumes spaced further apart.
The same gesture, different contexts.
What remains universal is the importance of donation: whether 200 or 500 mL, every contribution saves lives.
And while the volume may change, the human value of the gesture remains constant.”
Stay updated on the emerging in transfusion medicine with Hemostasis Today.
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA
-
Feb 28, 2026, 17:00Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro
-
Feb 28, 2026, 16:46Alfonso Tafur: Preventing Post-Hospitalization Blood Clots Using Precision Tools and Systems
-
Feb 28, 2026, 16:39Anel Karisik: Do Antidepressants Influence Swallowing Recovery After Acute Ischemic Stroke?
-
Feb 28, 2026, 16:38Akinchan Bhardwaj: Targeting SBK2 for Selective Inflammasome Resolution in Atherosclerosis